Overview
Eastman Q3 2025 revenue of $2.2 bln misses analyst expectations
Adjusted EPS for Q3 2025 misses analyst estimates
Company maintained "strong" operating cash flow of $402 mln, consistent with prior year
Outlook
Company projects full-year 2025 adjusted EPS between $5.40 and $5.65
Eastman expects operating cash flow to approach $1 bln in 2025
Company anticipates greater than normal seasonal volume decline in Q4 2025, especially in the consumer discretionary markets
Result Drivers
INVENTORY REDUCTION - Achieved $200 mln reduction in inventory from Q2 2025 levels, focusing on cash generation
COST MANAGEMENT - On track to reduce cost structure by over $75 mln in 2025, net of inflation
COMMERCIAL EXCELLENCE - Continued to defend product value and market share in a weakening economic environment
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Miss
$2.20 bln
$2.25 bln (13 Analysts)
Q3 Adjusted EPS
Miss
$1.14
$1.16 (16 Analysts)
Q3 EPS
$0.40
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", 8 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the specialty chemicals peer group is "buy"
Wall Street's median 12-month price target for Eastman Chemical Co is $75.00, about 20.6% above its October 31 closing price of $59.52
The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 9 three months ago
Press Release: ID:nBw4jyGRWa
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)